TRIFLUOPERAZINE DOES NOT AFFECT DOXORUBICIN CARDIOTOXICITY IN THE RAT

被引：0
|
作者：
VILLANI, F
MONTI, E
PICCININI, F
FAVALLI, L
DIONIGI, AR
LANZA, E
POGGI, P
机构：
[1] UNIV MILAN,CATTEDRA FARMACOL,I-20122 MILAN,ITALY
[2] UNIV PAVIA,CATTEDRA SAGGI & DOSAGGI FARMACOL,I-27100 PAVIA,ITALY
[3] UNIV PAVIA,IST ISTOL & EMBRIOL GEN,I-27100 PAVIA,ITALY
来源：
ANTICANCER RESEARCH | 1988年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：659 / 664
页数：6
相关论文
共 50 条
  • [31] DOXORUBICIN CARDIOTOXICITY IN THE RAT - COMPARISON OF ELECTROCARDIOGRAM, TRANSMEMBRANE POTENTIAL, AND STRUCTURAL EFFECTS
    JENSEN, RA
    ACTON, EM
    PETERS, JH
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (01) : 186 - 200
  • [32] Protective effect of curcumin nanoparticles against cardiotoxicity induced by doxorubicin in rat
    Mohammed, Haitham S.
    Hosny, Eman N.
    Khadrawy, Yasser A.
    Magdy, Merna
    Attia, Yasmen S.
    Sayed, Omnia A.
    AbdElaal, Mahmoud
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (05):
  • [33] Protective effects of agmatine on doxorubicin-induced chronic cardiotoxicity in rat
    Yarmohmmadi, Fatemeh
    Rahimi, Nastaran
    Faghir-Ghanesefat, Hedyeh
    Javadian, Nina
    Abdollahi, Alireza
    Pasalar, Parvin
    Jazayeri, Farahnaz
    Ejtemaeemehr, Shahram
    Dehpour, Ahmad Reza
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 796 : 39 - 44
  • [34] ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat
    Sacco, Giuseppe
    Bigioni, Mario
    Lopez, Giuseppe
    Evangelista, Stefano
    Manzini, Stefano
    Maggi, Carlo Alberto
    VASCULAR PHARMACOLOGY, 2009, 50 (5-6) : 166 - 170
  • [35] A rat model of doxorubicin-induced late-onset cardiotoxicity
    Gibson, Noah M.
    Lien, Chia-Ying
    Jensen, Brock T.
    Hydock, David S.
    Hayward, Reid
    FASEB JOURNAL, 2013, 27
  • [36] TRIFLUOPERAZINE DOES NOT INHIBIT THE ACUTE METABOLIC EFFECTS OF INSULIN IN RAT ADIPOCYTES
    KELLY, KL
    DICENZO, D
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (04) : 760 - 763
  • [37] Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats
    Karagoz, Bulent
    Suleymanoglu, Selami
    Uzun, Gunalp
    Bilgi, Oguz
    Aydinoz, Secil
    Haholu, Aptullah
    Turken, Orhan
    Onem, Yalcin
    Kandemir, E. Gokhan
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 (03) : 287 - 292
  • [38] Liraglutide Pretreatment Does Not Improve Acute Doxorubicin-Induced Cardiotoxicity in Rats
    Tonon, Carolina R.
    Monte, Marina G.
    Balin, Paola S.
    Fujimori, Anderson S. S.
    Ribeiro, Ana Paula D.
    Ferreira, Natalia F.
    Vieira, Nayane M.
    Cabral, Ronny P.
    Okoshi, Marina P.
    Okoshi, Katashi
    Zornoff, Leonardo A. M.
    Minicucci, Marcos F.
    Paiva, Sergio A. R.
    Gomes, Mariana J.
    Polegato, Bertha F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [39] Doxorubicin Cardiotoxicity: Pathophysiology Updates
    Christopher W. Hoeger
    Cole Turissini
    Aarti Asnani
    Current Treatment Options in Cardiovascular Medicine, 2020, 22
  • [40] Empagliflozin to Prevent Doxorubicin Cardiotoxicity
    Guo, Zhen
    Javaheri, Ali
    JACC: CARDIOONCOLOGY, 2025, 7 (02): : 185 - 187
12345